Back to Acceleration Radar
MTRNMaterion Corporation
Health Care · Industrial Specialties · Mid
$221.06+0.89%
As of 23 Oct 2026Mkt cap $5.0B
Stage 13
AVOID
Fundamentals
33.9/75
Technical
6.7/15
Independent
40.6/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- −13.7%
- 3M
- −8.6%
- 6M
- +18.9%
- 1Y
- +71.1%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 51.5xHist median 85.0x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 92.1x
- FCF yield
- 1.1%
Quality
- ROIC
- 7.7%
- Operating margin
- 6.1%
- FCF margin
- 2.8%
- Current ratio
- 3.1x
Growth
- Revenue growth
- +6.0%Latest FY YoY
- Revenue CAGR
- +4.3%
- EPS CAGR
- +0.6%
- FCF CAGR
- +21.5%
Capital
- Share-count trend
- +0.0%3Y annualised
- Net debt
- $425M4.1x OCF
Annual trend
- CAGR 2021–2025
- +4.3%
- Latest · 2025
- $2B
- YoY
- +6.0%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-04
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded